Nitric oxide (NO) is a pleiotropic regulator of vascular function, and its overproduction by inducible nitric-oxide synthase (iNOS) in inflammatory conditions plays an important role in the pathogenesis of vascular diseases. iNOS activity is thought to be regulated primarily at the level of expression to generate "high output" NO compared with constitutive NO synthases. Here we show iNOS activity is acutely up-regulated by activation of the B 1 -kinin receptor ( to Asp resulted in a basally hyperactive iNOS whose activity was not further increased by B 1 R agonist. ERK and phospho-ERK (after B 1 R activation) were co-localized with iNOS as determined by confocal fluorescence microscopy. Furthermore, ERK co-immunoprecipitated with iNOS. The discovery that iNOS can be phosphorylated by ERK and acutely activated by receptor-mediated signaling reveals a new level of regulation for this isoform. These findings provide a novel therapeutic target to explore in the treatment of vascular inflammatory diseases.
Endothelial cells are a key source of nitric oxide (NO),2 an important mediator of vascular function (1-4). In general, NO serves a protective function at low concentrations under normal conditions, but in inflammatory conditions and at high levels, NO may contribute to tissue damage, especially after reaction with superoxide to form peroxynitrite (5-7). Under normal conditions, the primary NO synthase (NOS) generating NO in the vasculature is endothelial NOS (eNOS). The activity of this constitutive isoform is closely regulated in a variety of ways, including changes in intracellular Ca 2ϩ levels, Ser or Thr phosphorylation, S-nitrosylation, and by interaction with other proteins (4, 8 -11). Under inflammatory conditions, endothelial cells can also express inducible NOS (iNOS) (12-14). In contrast to eNOS, iNOS is considered to be regulated primarily at the level of expression (15). Once expressed, iNOS is thought to continuously generate NO in the presence of sufficient cofactors and substrate until the protein is degraded (15, 16). These properties have led to the concept that iNOS generates high output NO in an unregulated fashion with primarily cytotoxic functions, for example in the host defense response (4). We showed that activation of the inducible kinin B 1 receptor (B 1 R) with peptide agonists or angiotensin-converting enzyme inhibitors directly stimulates high output NO production in cytokinetreated human lung microvascular endothelial cells (HLMVEC) (13,17). Surprisingly, the NO produced in response to B 1 R activation was generated primarily by iNOS (13), indicating the possibility of its acute, post-translational activation. We report here that B 1 R activation results in ERK1/2 activation and phosphorylation of Ser 745 in iNOS, resulting in a profound activation and generation of "super-high output" NO. Receptor-dependent activation of iNOS via phosphorylation reveals a new layer of complexity in the regulation of this enzyme that can play an important role in inflammatory conditions.
EXPERIMENTAL ...